Gregory Balani

Gregory Balani, PharmD, is a Senior Director, Head of Business Development at Escient Pharmaceuticals. Prior to their current role, Gregory held positions at companies such as Zogenix, Inc., Bayer, and Eli Lilly and Company, gaining experience in business development, mergers, acquisitions, and consulting. Gregory's educational background includes a Doctor of Pharmacy (Pharm.D.) from the University of California, San Francisco, and a Bachelor of Science (BS) in Finance/Economics from DePaul University.